Global Vaginal and Vulval Inflammatory Disease Treatment Supply, Demand and Key Producers, 2023-2029
The global Vaginal and Vulval Inflammatory Disease Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Vaginal and Vulval Inflammatory Disease Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaginal and Vulval Inflammatory Disease Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaginal and Vulval Inflammatory Disease Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaginal and Vulval Inflammatory Disease Treatment total market, 2018-2029, (USD Million)
Global Vaginal and Vulval Inflammatory Disease Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Vaginal and Vulval Inflammatory Disease Treatment total market, key domestic companies and share, (USD Million)
Global Vaginal and Vulval Inflammatory Disease Treatment revenue by player and market share 2018-2023, (USD Million)
Global Vaginal and Vulval Inflammatory Disease Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Vaginal and Vulval Inflammatory Disease Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Vaginal and Vulval Inflammatory Disease Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Almirall, VenusConcept, ThermiGen LLC, Lutronic, BTL Group of Companies, Viveve, Fotona, Evofem Biosciences, Inc. and Spero Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaginal and Vulval Inflammatory Disease Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vaginal and Vulval Inflammatory Disease Treatment Market, By Region:
1. How big is the global Vaginal and Vulval Inflammatory Disease Treatment market?
2. What is the demand of the global Vaginal and Vulval Inflammatory Disease Treatment market?
3. What is the year over year growth of the global Vaginal and Vulval Inflammatory Disease Treatment market?
4. What is the total value of the global Vaginal and Vulval Inflammatory Disease Treatment market?
5. Who are the major players in the global Vaginal and Vulval Inflammatory Disease Treatment market?
6. What are the growth factors driving the market demand?
This report studies the global Vaginal and Vulval Inflammatory Disease Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaginal and Vulval Inflammatory Disease Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaginal and Vulval Inflammatory Disease Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaginal and Vulval Inflammatory Disease Treatment total market, 2018-2029, (USD Million)
Global Vaginal and Vulval Inflammatory Disease Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Vaginal and Vulval Inflammatory Disease Treatment total market, key domestic companies and share, (USD Million)
Global Vaginal and Vulval Inflammatory Disease Treatment revenue by player and market share 2018-2023, (USD Million)
Global Vaginal and Vulval Inflammatory Disease Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Vaginal and Vulval Inflammatory Disease Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Vaginal and Vulval Inflammatory Disease Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Almirall, VenusConcept, ThermiGen LLC, Lutronic, BTL Group of Companies, Viveve, Fotona, Evofem Biosciences, Inc. and Spero Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaginal and Vulval Inflammatory Disease Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vaginal and Vulval Inflammatory Disease Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Vaginal Dryness
- Vaginal Burning
- Vaginal Discharge
- Genital Itching
- Recurrent Urinary Tract Infections
- Urinary Incontinence
- Others
- Hospital Pharmacies
- Specialty Clinics
- Others
- Almirall
- VenusConcept
- ThermiGen LLC
- Lutronic
- BTL Group of Companies
- Viveve
- Fotona
- Evofem Biosciences, Inc.
- Spero Therapeutics
- Hologic
- Kyung Hee University Hospital
1. How big is the global Vaginal and Vulval Inflammatory Disease Treatment market?
2. What is the demand of the global Vaginal and Vulval Inflammatory Disease Treatment market?
3. What is the year over year growth of the global Vaginal and Vulval Inflammatory Disease Treatment market?
4. What is the total value of the global Vaginal and Vulval Inflammatory Disease Treatment market?
5. Who are the major players in the global Vaginal and Vulval Inflammatory Disease Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Vaginal and Vulval Inflammatory Disease Treatment Introduction
1.2 World Vaginal and Vulval Inflammatory Disease Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Vaginal and Vulval Inflammatory Disease Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.3 China Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.4 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.5 Japan Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.6 South Korea Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.7 ASEAN Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.8 India Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaginal and Vulval Inflammatory Disease Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaginal and Vulval Inflammatory Disease Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.2 World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value by Region
2.2.1 World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value by Region (2018-2023)
2.2.2 World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.4 China Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.5 Europe Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.6 Japan Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.7 South Korea Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.8 ASEAN Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.9 India Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
3 WORLD VAGINAL AND VULVAL INFLAMMATORY DISEASE TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Vaginal and Vulval Inflammatory Disease Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Vaginal and Vulval Inflammatory Disease Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Vaginal and Vulval Inflammatory Disease Treatment in 2022
3.3 Vaginal and Vulval Inflammatory Disease Treatment Company Evaluation Quadrant
3.4 Vaginal and Vulval Inflammatory Disease Treatment Market: Overall Company Footprint Analysis
3.4.1 Vaginal and Vulval Inflammatory Disease Treatment Market: Region Footprint
3.4.2 Vaginal and Vulval Inflammatory Disease Treatment Market: Company Product Type Footprint
3.4.3 Vaginal and Vulval Inflammatory Disease Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Comparison
4.2.1 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Vaginal and Vulval Inflammatory Disease Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023)
4.4 China Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023)
4.5 Rest of World Based Vaginal and Vulval Inflammatory Disease Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vaginal Dryness
5.2.2 Vaginal Burning
5.2.3 Vaginal Discharge
5.2.4 Genital Itching
5.2.5 Recurrent Urinary Tract Infections
5.2.6 Urinary Incontinence
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023)
5.3.2 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2029)
5.3.3 World Vaginal and Vulval Inflammatory Disease Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Specialty Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023)
6.3.2 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2029)
6.3.3 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Almirall
7.1.1 Almirall Details
7.1.2 Almirall Major Business
7.1.3 Almirall Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.1.4 Almirall Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Almirall Recent Developments/Updates
7.1.6 Almirall Competitive Strengths & Weaknesses
7.2 VenusConcept
7.2.1 VenusConcept Details
7.2.2 VenusConcept Major Business
7.2.3 VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.2.4 VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 VenusConcept Recent Developments/Updates
7.2.6 VenusConcept Competitive Strengths & Weaknesses
7.3 ThermiGen LLC
7.3.1 ThermiGen LLC Details
7.3.2 ThermiGen LLC Major Business
7.3.3 ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.3.4 ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 ThermiGen LLC Recent Developments/Updates
7.3.6 ThermiGen LLC Competitive Strengths & Weaknesses
7.4 Lutronic
7.4.1 Lutronic Details
7.4.2 Lutronic Major Business
7.4.3 Lutronic Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.4.4 Lutronic Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Lutronic Recent Developments/Updates
7.4.6 Lutronic Competitive Strengths & Weaknesses
7.5 BTL Group of Companies
7.5.1 BTL Group of Companies Details
7.5.2 BTL Group of Companies Major Business
7.5.3 BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.5.4 BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 BTL Group of Companies Recent Developments/Updates
7.5.6 BTL Group of Companies Competitive Strengths & Weaknesses
7.6 Viveve
7.6.1 Viveve Details
7.6.2 Viveve Major Business
7.6.3 Viveve Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.6.4 Viveve Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Viveve Recent Developments/Updates
7.6.6 Viveve Competitive Strengths & Weaknesses
7.7 Fotona
7.7.1 Fotona Details
7.7.2 Fotona Major Business
7.7.3 Fotona Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.7.4 Fotona Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Fotona Recent Developments/Updates
7.7.6 Fotona Competitive Strengths & Weaknesses
7.8 Evofem Biosciences, Inc.
7.8.1 Evofem Biosciences, Inc. Details
7.8.2 Evofem Biosciences, Inc. Major Business
7.8.3 Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.8.4 Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Evofem Biosciences, Inc. Recent Developments/Updates
7.8.6 Evofem Biosciences, Inc. Competitive Strengths & Weaknesses
7.9 Spero Therapeutics
7.9.1 Spero Therapeutics Details
7.9.2 Spero Therapeutics Major Business
7.9.3 Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.9.4 Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Spero Therapeutics Recent Developments/Updates
7.9.6 Spero Therapeutics Competitive Strengths & Weaknesses
7.10 Hologic
7.10.1 Hologic Details
7.10.2 Hologic Major Business
7.10.3 Hologic Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.10.4 Hologic Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Hologic Recent Developments/Updates
7.10.6 Hologic Competitive Strengths & Weaknesses
7.11 Kyung Hee University Hospital
7.11.1 Kyung Hee University Hospital Details
7.11.2 Kyung Hee University Hospital Major Business
7.11.3 Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.11.4 Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Kyung Hee University Hospital Recent Developments/Updates
7.11.6 Kyung Hee University Hospital Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vaginal and Vulval Inflammatory Disease Treatment Industry Chain
8.2 Vaginal and Vulval Inflammatory Disease Treatment Upstream Analysis
8.3 Vaginal and Vulval Inflammatory Disease Treatment Midstream Analysis
8.4 Vaginal and Vulval Inflammatory Disease Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Vaginal and Vulval Inflammatory Disease Treatment Introduction
1.2 World Vaginal and Vulval Inflammatory Disease Treatment Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Vaginal and Vulval Inflammatory Disease Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.3 China Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.4 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.5 Japan Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.6 South Korea Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.7 ASEAN Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.3.8 India Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaginal and Vulval Inflammatory Disease Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaginal and Vulval Inflammatory Disease Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.2 World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value by Region
2.2.1 World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value by Region (2018-2023)
2.2.2 World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Forecast by Region (2024-2029)
2.3 United States Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.4 China Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.5 Europe Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.6 Japan Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.7 South Korea Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.8 ASEAN Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
2.9 India Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029)
3 WORLD VAGINAL AND VULVAL INFLAMMATORY DISEASE TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Vaginal and Vulval Inflammatory Disease Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Vaginal and Vulval Inflammatory Disease Treatment in 2022
3.2.3 Global Concentration Ratios (CR8) for Vaginal and Vulval Inflammatory Disease Treatment in 2022
3.3 Vaginal and Vulval Inflammatory Disease Treatment Company Evaluation Quadrant
3.4 Vaginal and Vulval Inflammatory Disease Treatment Market: Overall Company Footprint Analysis
3.4.1 Vaginal and Vulval Inflammatory Disease Treatment Market: Region Footprint
3.4.2 Vaginal and Vulval Inflammatory Disease Treatment Market: Company Product Type Footprint
3.4.3 Vaginal and Vulval Inflammatory Disease Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Comparison
4.2.1 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Vaginal and Vulval Inflammatory Disease Treatment Companies and Market Share, 2018-2023
4.3.1 United States Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023)
4.4 China Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue and Market Share, 2018-2023
4.4.1 China Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023)
4.5 Rest of World Based Vaginal and Vulval Inflammatory Disease Treatment Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vaginal Dryness
5.2.2 Vaginal Burning
5.2.3 Vaginal Discharge
5.2.4 Genital Itching
5.2.5 Recurrent Urinary Tract Infections
5.2.6 Urinary Incontinence
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023)
5.3.2 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2029)
5.3.3 World Vaginal and Vulval Inflammatory Disease Treatment Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Specialty Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023)
6.3.2 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2029)
6.3.3 World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Almirall
7.1.1 Almirall Details
7.1.2 Almirall Major Business
7.1.3 Almirall Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.1.4 Almirall Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Almirall Recent Developments/Updates
7.1.6 Almirall Competitive Strengths & Weaknesses
7.2 VenusConcept
7.2.1 VenusConcept Details
7.2.2 VenusConcept Major Business
7.2.3 VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.2.4 VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 VenusConcept Recent Developments/Updates
7.2.6 VenusConcept Competitive Strengths & Weaknesses
7.3 ThermiGen LLC
7.3.1 ThermiGen LLC Details
7.3.2 ThermiGen LLC Major Business
7.3.3 ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.3.4 ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 ThermiGen LLC Recent Developments/Updates
7.3.6 ThermiGen LLC Competitive Strengths & Weaknesses
7.4 Lutronic
7.4.1 Lutronic Details
7.4.2 Lutronic Major Business
7.4.3 Lutronic Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.4.4 Lutronic Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Lutronic Recent Developments/Updates
7.4.6 Lutronic Competitive Strengths & Weaknesses
7.5 BTL Group of Companies
7.5.1 BTL Group of Companies Details
7.5.2 BTL Group of Companies Major Business
7.5.3 BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.5.4 BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 BTL Group of Companies Recent Developments/Updates
7.5.6 BTL Group of Companies Competitive Strengths & Weaknesses
7.6 Viveve
7.6.1 Viveve Details
7.6.2 Viveve Major Business
7.6.3 Viveve Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.6.4 Viveve Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Viveve Recent Developments/Updates
7.6.6 Viveve Competitive Strengths & Weaknesses
7.7 Fotona
7.7.1 Fotona Details
7.7.2 Fotona Major Business
7.7.3 Fotona Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.7.4 Fotona Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Fotona Recent Developments/Updates
7.7.6 Fotona Competitive Strengths & Weaknesses
7.8 Evofem Biosciences, Inc.
7.8.1 Evofem Biosciences, Inc. Details
7.8.2 Evofem Biosciences, Inc. Major Business
7.8.3 Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.8.4 Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Evofem Biosciences, Inc. Recent Developments/Updates
7.8.6 Evofem Biosciences, Inc. Competitive Strengths & Weaknesses
7.9 Spero Therapeutics
7.9.1 Spero Therapeutics Details
7.9.2 Spero Therapeutics Major Business
7.9.3 Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.9.4 Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Spero Therapeutics Recent Developments/Updates
7.9.6 Spero Therapeutics Competitive Strengths & Weaknesses
7.10 Hologic
7.10.1 Hologic Details
7.10.2 Hologic Major Business
7.10.3 Hologic Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.10.4 Hologic Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Hologic Recent Developments/Updates
7.10.6 Hologic Competitive Strengths & Weaknesses
7.11 Kyung Hee University Hospital
7.11.1 Kyung Hee University Hospital Details
7.11.2 Kyung Hee University Hospital Major Business
7.11.3 Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Product and Services
7.11.4 Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Kyung Hee University Hospital Recent Developments/Updates
7.11.6 Kyung Hee University Hospital Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vaginal and Vulval Inflammatory Disease Treatment Industry Chain
8.2 Vaginal and Vulval Inflammatory Disease Treatment Upstream Analysis
8.3 Vaginal and Vulval Inflammatory Disease Treatment Midstream Analysis
8.4 Vaginal and Vulval Inflammatory Disease Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Vaginal and Vulval Inflammatory Disease Treatment Players in 2022
Table 12. World Vaginal and Vulval Inflammatory Disease Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Vaginal and Vulval Inflammatory Disease Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Vaginal and Vulval Inflammatory Disease Treatment Player
Table 15. Vaginal and Vulval Inflammatory Disease Treatment Market: Company Product Type Footprint
Table 16. Vaginal and Vulval Inflammatory Disease Treatment Market: Company Product Application Footprint
Table 17. Vaginal and Vulval Inflammatory Disease Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Vaginal and Vulval Inflammatory Disease Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share (2018-2023)
Table 23. China Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share (2018-2023)
Table 29. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. Almirall Basic Information, Area Served and Competitors
Table 36. Almirall Major Business
Table 37. Almirall Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 38. Almirall Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Almirall Recent Developments/Updates
Table 40. Almirall Competitive Strengths & Weaknesses
Table 41. VenusConcept Basic Information, Area Served and Competitors
Table 42. VenusConcept Major Business
Table 43. VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 44. VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. VenusConcept Recent Developments/Updates
Table 46. VenusConcept Competitive Strengths & Weaknesses
Table 47. ThermiGen LLC Basic Information, Area Served and Competitors
Table 48. ThermiGen LLC Major Business
Table 49. ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 50. ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. ThermiGen LLC Recent Developments/Updates
Table 52. ThermiGen LLC Competitive Strengths & Weaknesses
Table 53. Lutronic Basic Information, Area Served and Competitors
Table 54. Lutronic Major Business
Table 55. Lutronic Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 56. Lutronic Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Lutronic Recent Developments/Updates
Table 58. Lutronic Competitive Strengths & Weaknesses
Table 59. BTL Group of Companies Basic Information, Area Served and Competitors
Table 60. BTL Group of Companies Major Business
Table 61. BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 62. BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BTL Group of Companies Recent Developments/Updates
Table 64. BTL Group of Companies Competitive Strengths & Weaknesses
Table 65. Viveve Basic Information, Area Served and Competitors
Table 66. Viveve Major Business
Table 67. Viveve Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 68. Viveve Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Viveve Recent Developments/Updates
Table 70. Viveve Competitive Strengths & Weaknesses
Table 71. Fotona Basic Information, Area Served and Competitors
Table 72. Fotona Major Business
Table 73. Fotona Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 74. Fotona Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Fotona Recent Developments/Updates
Table 76. Fotona Competitive Strengths & Weaknesses
Table 77. Evofem Biosciences, Inc. Basic Information, Area Served and Competitors
Table 78. Evofem Biosciences, Inc. Major Business
Table 79. Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 80. Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Evofem Biosciences, Inc. Recent Developments/Updates
Table 82. Evofem Biosciences, Inc. Competitive Strengths & Weaknesses
Table 83. Spero Therapeutics Basic Information, Area Served and Competitors
Table 84. Spero Therapeutics Major Business
Table 85. Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 86. Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Spero Therapeutics Recent Developments/Updates
Table 88. Spero Therapeutics Competitive Strengths & Weaknesses
Table 89. Hologic Basic Information, Area Served and Competitors
Table 90. Hologic Major Business
Table 91. Hologic Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 92. Hologic Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Hologic Recent Developments/Updates
Table 94. Kyung Hee University Hospital Basic Information, Area Served and Competitors
Table 95. Kyung Hee University Hospital Major Business
Table 96. Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 97. Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment Upstream (Raw Materials)
Table 99. Vaginal and Vulval Inflammatory Disease Treatment Typical Customers
Table 1. World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Vaginal and Vulval Inflammatory Disease Treatment Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Vaginal and Vulval Inflammatory Disease Treatment Players in 2022
Table 12. World Vaginal and Vulval Inflammatory Disease Treatment Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Vaginal and Vulval Inflammatory Disease Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Vaginal and Vulval Inflammatory Disease Treatment Player
Table 15. Vaginal and Vulval Inflammatory Disease Treatment Market: Company Product Type Footprint
Table 16. Vaginal and Vulval Inflammatory Disease Treatment Market: Company Product Application Footprint
Table 17. Vaginal and Vulval Inflammatory Disease Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Vaginal and Vulval Inflammatory Disease Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share (2018-2023)
Table 23. China Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share (2018-2023)
Table 26. Rest of World Based Vaginal and Vulval Inflammatory Disease Treatment Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share (2018-2023)
Table 29. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023) & (USD Million)
Table 31. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2029) & (USD Million)
Table 32. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023) & (USD Million)
Table 34. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2029) & (USD Million)
Table 35. Almirall Basic Information, Area Served and Competitors
Table 36. Almirall Major Business
Table 37. Almirall Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 38. Almirall Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Almirall Recent Developments/Updates
Table 40. Almirall Competitive Strengths & Weaknesses
Table 41. VenusConcept Basic Information, Area Served and Competitors
Table 42. VenusConcept Major Business
Table 43. VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 44. VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. VenusConcept Recent Developments/Updates
Table 46. VenusConcept Competitive Strengths & Weaknesses
Table 47. ThermiGen LLC Basic Information, Area Served and Competitors
Table 48. ThermiGen LLC Major Business
Table 49. ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 50. ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. ThermiGen LLC Recent Developments/Updates
Table 52. ThermiGen LLC Competitive Strengths & Weaknesses
Table 53. Lutronic Basic Information, Area Served and Competitors
Table 54. Lutronic Major Business
Table 55. Lutronic Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 56. Lutronic Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Lutronic Recent Developments/Updates
Table 58. Lutronic Competitive Strengths & Weaknesses
Table 59. BTL Group of Companies Basic Information, Area Served and Competitors
Table 60. BTL Group of Companies Major Business
Table 61. BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 62. BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BTL Group of Companies Recent Developments/Updates
Table 64. BTL Group of Companies Competitive Strengths & Weaknesses
Table 65. Viveve Basic Information, Area Served and Competitors
Table 66. Viveve Major Business
Table 67. Viveve Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 68. Viveve Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Viveve Recent Developments/Updates
Table 70. Viveve Competitive Strengths & Weaknesses
Table 71. Fotona Basic Information, Area Served and Competitors
Table 72. Fotona Major Business
Table 73. Fotona Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 74. Fotona Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Fotona Recent Developments/Updates
Table 76. Fotona Competitive Strengths & Weaknesses
Table 77. Evofem Biosciences, Inc. Basic Information, Area Served and Competitors
Table 78. Evofem Biosciences, Inc. Major Business
Table 79. Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 80. Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Evofem Biosciences, Inc. Recent Developments/Updates
Table 82. Evofem Biosciences, Inc. Competitive Strengths & Weaknesses
Table 83. Spero Therapeutics Basic Information, Area Served and Competitors
Table 84. Spero Therapeutics Major Business
Table 85. Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 86. Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Spero Therapeutics Recent Developments/Updates
Table 88. Spero Therapeutics Competitive Strengths & Weaknesses
Table 89. Hologic Basic Information, Area Served and Competitors
Table 90. Hologic Major Business
Table 91. Hologic Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 92. Hologic Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Hologic Recent Developments/Updates
Table 94. Kyung Hee University Hospital Basic Information, Area Served and Competitors
Table 95. Kyung Hee University Hospital Major Business
Table 96. Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Product and Services
Table 97. Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment Upstream (Raw Materials)
Table 99. Vaginal and Vulval Inflammatory Disease Treatment Typical Customers
LIST OF FIGURES
Figure 1. Vaginal and Vulval Inflammatory Disease Treatment Picture
Figure 2. World Vaginal and Vulval Inflammatory Disease Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vaginal and Vulval Inflammatory Disease Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Vaginal and Vulval Inflammatory Disease Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Vaginal and Vulval Inflammatory Disease Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Vaginal and Vulval Inflammatory Disease Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Vaginal and Vulval Inflammatory Disease Treatment Markets in 2022
Figure 27. United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Vaginal and Vulval Inflammatory Disease Treatment Market Size Market Share by Type in 2022
Figure 31. Vaginal Dryness
Figure 32. Vaginal Burning
Figure 33. Vaginal Discharge
Figure 34. Genital Itching
Figure 35. Recurrent Urinary Tract Infections
Figure 36. Urinary Incontinence
Figure 37. Others
Figure 38. World Vaginal and Vulval Inflammatory Disease Treatment Market Size Market Share by Type (2018-2029)
Figure 39. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Vaginal and Vulval Inflammatory Disease Treatment Market Size Market Share by Application in 2022
Figure 41. Hospital Pharmacies
Figure 42. Specialty Clinics
Figure 43. Others
Figure 44. Vaginal and Vulval Inflammatory Disease Treatment Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
Figure 1. Vaginal and Vulval Inflammatory Disease Treatment Picture
Figure 2. World Vaginal and Vulval Inflammatory Disease Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vaginal and Vulval Inflammatory Disease Treatment Total Market Size (2018-2029) & (USD Million)
Figure 4. World Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Vaginal and Vulval Inflammatory Disease Treatment Revenue (2018-2029) & (USD Million)
Figure 13. Vaginal and Vulval Inflammatory Disease Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 16. World Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. China Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. India Vaginal and Vulval Inflammatory Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Vaginal and Vulval Inflammatory Disease Treatment by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Vaginal and Vulval Inflammatory Disease Treatment Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Vaginal and Vulval Inflammatory Disease Treatment Markets in 2022
Figure 27. United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vaginal and Vulval Inflammatory Disease Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Vaginal and Vulval Inflammatory Disease Treatment Market Size Market Share by Type in 2022
Figure 31. Vaginal Dryness
Figure 32. Vaginal Burning
Figure 33. Vaginal Discharge
Figure 34. Genital Itching
Figure 35. Recurrent Urinary Tract Infections
Figure 36. Urinary Incontinence
Figure 37. Others
Figure 38. World Vaginal and Vulval Inflammatory Disease Treatment Market Size Market Share by Type (2018-2029)
Figure 39. World Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Vaginal and Vulval Inflammatory Disease Treatment Market Size Market Share by Application in 2022
Figure 41. Hospital Pharmacies
Figure 42. Specialty Clinics
Figure 43. Others
Figure 44. Vaginal and Vulval Inflammatory Disease Treatment Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
